Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in ...

What recent performance says about Novavax Novavax (NVAX) has been moving on the radar again, with shares showing a mix of ...

Novavax (NVAX) closed at $9.62 in the latest trading session, marking a -1.23% move from the prior day. The stock exceeded ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Valneva (NASDAQ:VALN) executives highlighted steady full-year 2025 revenue, tighter cash discipline, and multiple clinical ...

The Trump administration weighs candidates to lead the CDC, with two physicians with contrasting views on vaccines ...

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.